Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5154)
All Articles published online
|
Aug 28, 2012 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | van der Marel S, Majowicz A, Kwikkers K, van Logtenstein R, te Velde AA, De Groot AS, Meijer SL, van Deventer SJ, Petry H, Hommes DW, Ferreira V. Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis. World J Gastroenterol 2012; 18(32): 4288-4299 [PMID: 22969191 DOI: 10.3748/wjg.v18.i32.4288] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i32/4288.htm |
| Number | Citing Articles |
| 1 |
Miglena G. Prabagar, Hyeong-jwa Choi, Jin-Yeon Park, Sohee Loh, Young-Sun Kang. Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute. Clinical and Experimental Medicine 2014; 14(4): 361 doi: 10.1007/s10238-013-0255-4
|
| 2 |
Anne S. De Groot, Leslie Cousens, Federico Mingozzi, William Martin. Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/493138
|
| 3 |
Christian W. Grant, Catherine M. Moran-Paul, Shane K. Duclos, Dennis L. Guberski, Guillermo Arreaza-Rubín, Lisa M. Spain, Paolo Fiorina. Testing Agents for Prevention or Reversal of Type 1 Diabetes in Rodents. PLoS ONE 2013; 8(8): e72989 doi: 10.1371/journal.pone.0072989
|
| 4 |
Leslie P. Cousens, Ryan Tassone, Bruce D. Mazer, Vasanthi Ramachandiran, David W. Scott, Anne S. De Groot. Tregitope update: Mechanism of action parallels IVIg. Autoimmunity Reviews 2013; 12(3): 436 doi: 10.1016/j.autrev.2012.08.017
|
| 5 |
Leslie P. Cousens, Yan Su, Elizabeth McClaine, Xin Li, Frances Terry, Robert Smith, Jinhee Lee, William Martin, David W. Scott, Anne S. De Groot. Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes. Journal of Diabetes Research 2013; 2013: 1 doi: 10.1155/2013/621693
|
| 6 |
Marieme Dembele, Shao Tao, Amir H. Massoud, S. M. Shahjahan Miah, Sandra Lelias, Anne S. De Groot, Bruce D. Mazer. Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.634509
|
| 7 |
Fatemeh Faraji, Zahra Karjoo, Maryam Vakili Moghaddam, Sahel Heidari, Reza Zolfaghari Emameh, Reza Falak. Challenges related to the immunogenicity of parenteral recombinant proteins: Underlying mechanisms and new approaches to overcome it. International Reviews of Immunology 2018; 37(6): 301 doi: 10.1080/08830185.2018.1471139
|
| 8 |
Aimee E. Mattei, Andres H. Gutierrez, Soorya Seshadri, Jacob Tivin, Matt Ardito, Amy S. Rosenberg, William D. Martin, Anne S. De Groot. In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies. mAbs 2024; 16(1) doi: 10.1080/19420862.2024.2333729
|
| 9 |
Moslem Javidan, Amir Mohamad Amiri, Narges Koohi, Nazanin Joudaki, Mohammad Ali Bashirrohelleh, Ali Pirsadeghi, Ali Farhadi Biregani, Mohammad Rashno, Mohammad Ghasemi Dehcheshmeh, Moosa Sharifat, Ali Khodadadi, Ladan Mafakher. Restoring immune balance with Tregitopes: A new approach to treating immunological disorders. Biomedicine & Pharmacotherapy 2024; 177: 116983 doi: 10.1016/j.biopha.2024.116983
|
| 10 |
Vibha Jawa, Leslie P. Cousens, Michel Awwad, Eric Wakshull, Harald Kropshofer, Anne S. De Groot. T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation. Clinical Immunology 2013; 149(3): 534 doi: 10.1016/j.clim.2013.09.006
|
| 11 |
Anne S. De Groot, Amy S. Rosenberg, S.M. Shahjahan Miah, Gail Skowron, Brian J. Roberts, Sandra Lélias, Frances E. Terry, William D. Martin. Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses. Clinical Immunology 2021; 224: 108661 doi: 10.1016/j.clim.2020.108661
|
| 12 |
Daniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, Robert J Davidson, George Buchlis, Mustafa Yazicioglu, Gary C Pien, Jonathan D Finn, Virginia Haurigot, Alex Tai, David W Scott, Leslie P Cousens, Shangzhen Zhou, Anne S De Groot, Federico Mingozzi. Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Molecular Therapy 2013; 21(9): 1727 doi: 10.1038/mt.2013.166
|
| 13 |
Leslie P. Cousens, Leonard Moise, Anne S. De Groot. Biobetters. AAPS Advances in the Pharmaceutical Sciences Series 2015; 19: 63 doi: 10.1007/978-1-4939-2543-8_5
|
| 14 |
Etiena Basner-Tschakarjan, Federico Mingozzi. Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00350
|
| 15 |
S. M. Shahjahan Miah, Sandra Lelias, Andres H. Gutierrez, Mitchell McAllister, Christine M. Boyle, Lenny Moise, Anne S. De Groot. A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1290688
|
| 16 |
Olga Hartwig, Maryam A. Shetab Boushehri, Karim S. Shalaby, Brigitta Loretz, Alf Lamprecht, Claus-Michael Lehr. Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD. Advanced Drug Delivery Reviews 2021; 175: 113828 doi: 10.1016/j.addr.2021.113828
|